Geographical Differences in the Epidemiology and Treatment of Candida Prosthetic Joint Infections
Open Forum Infectious Diseases · 30.03.2026 · 13 (4)
DOI: 10.1093/ofid/ofag208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 15.04.2026. Verfasst von Christel Mamona-Kilu und 34 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Department, Raymond-Poincaré University Hospital, Paris Saclay University, Assistance Publique-Hôpitaux de Paris (AP-HP), Garches,…. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Management of prosthetic joint infections (PJIs) due to Candida spp. remains challenging and poorly standardized. Epidemiological patterns and therapeutic strategies may vary between centers and countries, potentially reflecting differences in access to antifungal agents.
Methods
We performed a secondary analysis of an international, multicenter, retrospective study supported by the European Society of Clinical Microbiology and Infectious Diseases, including Candida PJI diagnosed between 2010 and 2020. Cases met European Bone and Joint Infection Society criteria, combining clinical signs of infection with at least 2 intraoperative samples positive for Candida spp. Follow-up was 2 years. Epidemiology, management, and outcomes were compared across 5 groups: France, Spain, England, Austria, and other countries.
Results
Overall, 268 cases were included: France (n = 142), Spain (n = 42), England (n = 38), Austria (n = 36), and others (Brazil, Lithuania, Italy; n = 9). Distribution of infected sites was similar across countries (hip 53.4%, knee 43.3%, and other 3.3%), as was species epidemiology (Candida albicans 55.6%, Candida parapsilosis 29.5%, Candida glabrata 7.8%, and Candida tropicalis 5.6%). Surgical strategies differed: 1-stage exchange was more frequent in France (36.0%) and Austria (34.3%), whereas 2-stage exchange predominated in England (42.1%) and Spain (37.2%). Echinocandins were prescribed significantly more often in France (41.8%) than elsewhere. Overall outcomes were poor, with a global failure rate of 43%, without significant differences between countries.
Conclusions
International differences in epidemiology and management of Candida PJI appear limited. Variations in surgical and antifungal strategies did not translate into improved outcomes, highlighting the need for optimized and standardized management approaches in future collaborative prospective studies worldwide and clinical.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Infectious Disease Department, Raymond-Poincaré University Hospital, Paris Saclay University, Assistance Publique-Hôpitaux de Paris (AP-HP), Garches, France.
- Infectious Disease Department, Infectious Disease Hospital Universitario 12 de Octubre, Madrid, Spain.
- Nuffield Orthopaedic Centre, Oxford University Hospitals, Oxford, UK.
- Infectious Disease, Joseph Ducuing Hospital, Toulouse, France.
- Infectious Diseases Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
- Infection Disease, University Hospital, Tourcoing, France.
ORCID-Profile: Christel Mamona-Kilu, Martin McNally, Laura Escolà-Vergé, Eric Senneville, Maria Luisa Sorlí Redó, Stéphane Corvec, Jaime Esteban, Mikel Mancheño-Losa, José María Barbero Allende, Alex Soriano, Aurélien Dinh
Zitieren
APA
Mamona-Kilu, C., Lora-Tamayo, J., McNally, M., Duran, C., Ho, R., Scarborough, M., Dudareva, M., Bonnet, E., Escolà-Vergé, L., Pardo, D. R., Jesuthasan, G., Senneville, E., Thill, P., Klein, S., Ronde-Oustau, C., Redó, M. L. S., Corvec, S., Rossi, N., Esteban, J., …, & European Society of Clinical Microbiology and Infectious Diseases Study Group on Implant Associated Infections (ESGIAI) (2026). Geographical Differences in the Epidemiology and Treatment of Candida Prosthetic Joint Infections. Open Forum Infectious Diseases, 13(4). https://doi.org/10.1093/ofid/ofag208
Vancouver
Mamona-Kilu C, Lora-Tamayo J, McNally M, Duran C, Ho R, Scarborough M, et al. Geographical Differences in the Epidemiology and Treatment of Candida Prosthetic Joint Infections. Open Forum Infectious Diseases. 2026;13(4). doi:10.1093/ofid/ofag208
BibTeX
@article{MamonaKilu2026,
author = {Mamona-Kilu, Christel and Lora-Tamayo, Jaime and McNally, Martin and Duran, Clara and Ho, Rosemary and Scarborough, Matthew and Dudareva, Maria and Bonnet, Eric and Escolà-Vergé, Laura and Pardo, Dolores Rodriguez and Jesuthasan, Gerald and Senneville, Eric and Thill, Pauline and Klein, Stéphane and Ronde-Oustau, Cécile and Redó, Maria Luisa Sorlí and Corvec, Stéphane and Rossi, Nicolò and Esteban, Jaime and Lemaignen, Adrien and Ribeiro, Taiana Cunha and Mazet, Julien and Sasso, Milène and Costa Salles, Mauro José and Mancheño-Losa, Mikel and Giordano, Gérard and Frank, Bernhard J H and Hofstaetter, Jochen G and Allende, José María Barbero and Lortholary, Olivier and Fourcade, Camille and Morata, Laura and Soriano, Alex and Dinh, Aurélien and European Society of Clinical Microbiology and Infectious Diseases Study Group on Implant Associated Infections (ESGIAI), European Society of Clinical Microbiology and Infectious Diseases Study Group on Implant Associated Infections (ESGIAI)},
title = {Geographical Differences in the Epidemiology and Treatment of Candida Prosthetic Joint Infections},
journal = {Open Forum Infectious Diseases},
year = {2026},
volume = {13},
number = {4},
doi = {10.1093/ofid/ofag208}
}
EUVIMED